Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis

Rationale: Chronic azithromycin is commonly used in cystic fibrosis based on short controlled clinical trials showing reductions in pulmonary exacerbations and improved FEV(1). Long-term effects are unknown. Objectives: Examine pulmonary outcomes among chronic azithromycin users compared with matche...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Respir Crit Care Med
Главные авторы: Nichols, Dave P., Odem-Davis, Katherine, Cogen, Jonathan D., Goss, Christopher H., Ren, Clement L., Skalland, Michelle, Somayaji, Ranjani, Heltshe, Sonya L.
Формат: Artigo
Язык:Inglês
Опубликовано: American Thoracic Society 2020
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049934/
https://ncbi.nlm.nih.gov/pubmed/31661302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1206OC
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы